Establishing the Incidences of BRCA1 and BRCA2 Mutation by Combining DHPLC and Direct Sequencing in Ovarian Cancer

NCT00155896 · clinicaltrials.gov ↗
UNKNOWN
Status
100
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

National Taiwan University Hospital